Lmg Wealth Partners, LLC Precigen, Inc. Transaction History

Lmg Wealth Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$1.08 - $1.85 $803 - $1,376	-744 Reduced 3.1%	23,232 $33 Million
Q2 2023 Jul 27, 2023	SELL	$0.96 - $1.4 $430 - $627	-448 Reduced 1.83%	23,976 $27.6 Million
Q1 2023 May 02, 2023	SELL	$0.88 - $2.19 $1,398 - $3,479	-1,589 Reduced 6.11%	24,424 $25.9 Million
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $33,036 - $58,789	26,013 New	26,013 $54.4 Million

142

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $318M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Lmg Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Lmg Wealth Partners, LLC with notifications on news.